Kim Lyerly MD

Kim Lyerly

Core Faculty

Kim Lyerly, MD


MD, University of California at Los Angeles

Crosby EJ, Hobeika AC, Niedzwiecki D, Rushing C, Hsu D, Berglund P, et al. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. J Immunother Cancer. 2020 Nov;8(2).

Schrott R, Rajavel M, Acharya K, Huang Z, Acharya C, Hawkey A, et al. Sperm DNA methylation altered by THC and nicotine: Vulnerability of neurodevelopmental genes with bivalent chromatin. Sci Rep. 2020 Sep 29;10(1):16022.

Hafez N, Rugo HS, Tempero MA, Fox E, Reaman GH, Lyerly HK, et al. Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting. Clin Cancer Res. 2020 Sep 15;26(18):4743–7.